BELLAGIO MEDICAL S.R.L.

What BELLAGIO MEDICAL S.R.L. does

Bellagio Medical S.R.L. is a privately held medical device company, incorporated as an Italian limited liability company (S.R.L.) in 2025, focused on developing ophthalmic surgical devices for the management of glaucoma. Its lead and only publicly disclosed asset is Titran, a titratable glaucoma implant — a surgical device whose post-operative adjustability of intraocular pressure control differentiates it from conventional non-titratable glaucoma drainage implants. The company operates from a web presence at bellagio-medical.com and is currently in an early, pre-commercial stage of development.

No substantive product specifications, clinical status, regulatory pathway (CE mark, FDA 510(k) or PMA), manufacturing partnerships, distribution arrangements, management team, scientific advisory board, funding history, headcount, or revenue figures are publicly disclosed. The corporate website, at the time of data collection, presents only a verification/loading placeholder page and yields no operating data, product imagery, or pipeline information beyond the company-level description.

Given its 2025 vintage, single-asset focus on a titratable glaucoma implant, and absence of disclosed capital, clinical, or commercial milestones, Bellagio Medical should be characterized as an early-stage, lightly capitalized ophthalmic hardware developer. Investors and acquirers should treat the entity as an emerging, unverified market participant pending disclosure of regulatory strategy, clinical data, financing, and management.

Name

BELLAGIO MEDICAL S.R.L.

Legal name

BELLAGIO MEDICAL S.R.L.

Website

https://bellagio-medical.com

Company type

Private

Founded year

2025

Short description

Bellagio Medical S.R.L. is a privately held Italian ophthalmic medical device company founded in 2025 developing Titran, a titratable glaucoma implant intended for surgical management of intraocular pressure in glaucoma patients.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAHAJAI

Glaucoma Diagnostics & Surgical Devices (Tonometry, Gonioscopy, MIGS, Drainage Implants, Laser Trabeculoplasty)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)

Keywords

• Ophthalmic surgical devices
• Glaucoma implants
• Medical device manufacturing
• Ophthalmology equipment
• Eye surgery devices

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Core offering

BELLAGIO MEDICAL S.R.L. develops ophthalmic surgical devices, with its lead offering being the Titran titratable glaucoma implant — a medical device intended for surgical treatment of glaucoma in ophthalmology patients. The company operates as an Italian limited liability company (S.R.L.) focused on the research, development, and commercialization of specialized ophthalmic implants.

Differentiator

Problem solved

Functional benefit

Products and services

• Titran Titran is a titratable glaucoma implant — an ophthalmic surgical device designed for use in glaucoma surgery, allowing clinicians to titrate (adjust) the implant's effect post-operatively to manage intraocular pressure. It is intended for glaucoma surgeons and ophthalmology clinical buyers treating patients with glaucoma.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Direct peers

• Glaukos Corporation: Glaukos is the leading pure-play MIGS and glaucoma drainage implant company (iStent), directly comparable to Bellagio Medical as a specialist in interventional glaucoma surgical devices targeting medication reduction.
• New World Medical: New World Medical manufactures glaucoma drainage devices (Ahmed, Baerveldt implants) and other ophthalmic surgical products, directly competing in the glaucoma drainage implant category.
• Sight Sciences: Sight Sciences develops interventional ophthalmic surgical devices for glaucoma (OMNI Surgical System) and dry eye, making it a direct peer focused on MIGS and glaucoma surgical interventions.

Broad incumbents

• AbbVie (Allergan Aesthetics/eye care): AbbVie owns the former Allergan eye care franchise including the XEN Gel Stent glaucoma drainage implant, making it a broad incumbent competitor in the glaucoma surgical device market.
• Alcon: Alcon is the largest ophthalmic surgical device company globally, offering cataract, vitreoretinal, and glaucoma surgical products (including the Hydrus MIGS device acquired from Ivantis), competing broadly in the same surgical channels Bellagio Medical would target.
• BVI Medical: BVI Medical is a broad ophthalmic surgical device company offering cataract, vitreoretinal, and glaucoma surgical products, providing portfolio overlap with Bellagio Medical's surgical device focus.

Emerging players

• MicroOptx: MicroOptx is an early-stage company developing an ab-interno suprachoroidal glaucoma drainage implant, comparable as a small emerging glaucoma implant specialist with similar technology category.
• iSTAR Medical: iSTAR Medical develops the MINIject supraciliary MIGS implant for glaucoma, representing an emerging glaucoma implant specialist with similar device-category focus to Bellagio Medical.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat1 record

Key risks4 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BELLAGIO MEDICAL S.R.L.